The research also found the initial omega-3 fatty acid levels in a heart patient’s blood significantly affect whether the patient will respond to omega-3 supplements to treat depression. For instance, people with higher levels of omega-3 in their blood may benefit more from additional omega-3, in the form of supplements, than those whose blood levels of the fatty acids were lower at the outset.
“Most researchers have relied on dietary information,” Dr. Carney said. “You can make a crude estimate based on that information, but we found in our new study that there was a relatively weak correlation between what patients report about omega-3 in their diets and their actual blood levels.”
The study is published in The Journal of Clinical Psychiatry.
More articles on heart health:
Population health program reduces heart disease risk factors in local community
UAB research reveals link between spring daylight savings and increased heart attacks
Slow gait after a heart attack linked to readmission and loss of life, study finds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
